What is Durvalumab?

Category: Prescription Drugs

Most popular types: Imfinzi


Durvalumab is a programmed death ligand 1 blocking antibody that is used for the treatment of advanced stages of urothelial carcinoma and certain types of non-small cell lung cancer.


Based on patients currently taking Durvalumab

Dosage Patients
50 mg every other week 1


Currently taking Durvalumab

Duration Patients
6 months - 1 year 1
Last updated:
There are no evaluations for Durvalumab.